{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T07:05:51Z","timestamp":1756191951235},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","revespcardiol.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.rec.2017.10.028","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T01:45:42Z","timestamp":1512092742000},"page":"743-749","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol"],"prefix":"10.1016","volume":"71","author":[{"given":"Ji-won","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin Yi","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Young","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Seok","family":"Ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiick","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Mok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joonghyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keumhee","family":"Carriere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Hyeon","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-A.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2017.10.028_bib0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature."},{"key":"10.1016\/j.rec.2017.10.028_bib0215","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4070\/kcj.2016.46.6.841","article-title":"Clinical characteristics of Marfan syndrome in Korea","volume":"46","author":"Lim","year":"2016","journal-title":"Korean Circ J."},{"key":"10.1016\/j.rec.2017.10.028_bib0220","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome","volume":"330","author":"Shores","year":"1994","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2017.10.028_bib0225","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.ijcard.2013.03.033","article-title":"Circulating transforming growth factor-beta as a prognostic biomarker in Marfan syndrome","volume":"168","author":"Franken","year":"2013","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2017.10.028_bib0230","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science."},{"key":"10.1016\/j.rec.2017.10.028_bib0235","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat Genet."},{"key":"10.1016\/j.rec.2017.10.028_bib0240","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2017.10.028_bib0245","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","article-title":"Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial","volume":"34","author":"Groenink","year":"2013","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2017.10.028_bib0250","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan's syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2017.10.028_bib0255","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","article-title":"Marfan Sartan: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Milleron","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2017.10.028_bib0260","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/eurheartj\/ehv575","article-title":"Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial","volume":"37","author":"Forteza","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2017.10.028_bib0265","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/1470320311408751","article-title":"Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cells","volume":"12","author":"Ferri","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.rec.2017.10.028_bib0270","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ajh.2010.231","article-title":"Renal protective effects of aliskiren beyond its antihypertensive property in a mouse model of progressive fibrosis","volume":"24","author":"Gross","year":"2011","journal-title":"Am J Hypertens."},{"key":"10.1016\/j.rec.2017.10.028_bib0275","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ajh.2012.14","article-title":"Aliskiren and perindopril reduce the levels of transforming growth factor-beta in patients with non-diabetic kidney disease","volume":"25","author":"Lizakowski","year":"2012","journal-title":"Am J Hypertens."},{"key":"10.1016\/j.rec.2017.10.028_bib0280","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ehj.2004.04.033","article-title":"Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome","volume":"25","author":"Nollen","year":"2004","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2017.10.028_bib0285","first-page":"1462","article-title":"2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"28","author":"Mancia","year":"2007","journal-title":"Eur Heart J."},{"issue":"25 Suppl 1","key":"10.1016\/j.rec.2017.10.028_bib0290","first-page":"IV31","article-title":"Surrogate markers for cardiovascular disease: functional markers","volume":"109","author":"Cohn","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2017.10.028_bib0295","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/jmri.22646","article-title":"Age-related and regional changes of aortic stiffness in the Marfan syndrome: assessment with velocity-encoded MRI","volume":"34","author":"Westenberg","year":"2011","journal-title":"J Magn Reson Imaging."},{"key":"10.1016\/j.rec.2017.10.028_bib0300","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0008-6363(99)00095-4","article-title":"The influence of aging and aortic stiffness on permanent dilation and breaking stress of the thoracic descending aorta","volume":"43","author":"Groenink","year":"1999","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.rec.2017.10.028_bib0305","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/ajh\/7.2.168","article-title":"Arterial stiffness and wave reflections following acute calcium blockade in essential hypertension","volume":"7","author":"Pannier","year":"1994","journal-title":"Am J Hypertens."},{"key":"10.1016\/j.rec.2017.10.028_bib0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.jhh.1000581","article-title":"Assessment of the acute arterial effects of converting enzyme inhibition in essential hypertension: a double-blind, comparative and crossover study","volume":"12","author":"Topouchian","year":"1998","journal-title":"J Hum Hypertens."},{"key":"10.1016\/j.rec.2017.10.028_bib0315","first-page":"381","article-title":"Converting enzyme inhibition: dissociation between antihypertensive and arterial effects","volume":"6","author":"Asmar","year":"1992","journal-title":"J Hum Hypertens."},{"key":"10.1016\/j.rec.2017.10.028_bib0320","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10554-013-0206-x","article-title":"Assessment of regional aortic stiffness with cardiac magnetic resonance imaging in a healthy Asian population","volume":"29 Suppl 1","author":"Kim","year":"2013","journal-title":"Int J Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2017.10.028_bib0325","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jacc.2010.12.017","article-title":"Aortic stiffness: current understanding and future directions","volume":"57","author":"Cavalcante","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2017.10.028_bib0330","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9149(98)00315-4","article-title":"Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome","volume":"82","author":"Groenink","year":"1998","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2017.10.028_bib0335","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.ijcard.2012.08.057","article-title":"MRI-assessed regional pulse wave velocity for predicting absence of regional aorta luminal growth in marfan syndrome","volume":"167","author":"Kroner","year":"2013","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2017.10.028_bib0340","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1532-429X-14-77","article-title":"Normal values of aortic dimensions, distensibility, and pulse wave velocity in children and young adults: a cross-sectional study","volume":"14","author":"Voges","year":"2012","journal-title":"J Cardiovasc Magn Reson."},{"key":"10.1016\/j.rec.2017.10.028_bib0345","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4065\/mcp.2009.0336","article-title":"Noninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform?","volume":"85","author":"Nelson","year":"2010","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.rec.2017.10.028_bib0350","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3349\/ymj.2015.56.3.617","article-title":"Brachial-ankle pulse wave velocity as a screen for arterial stiffness: a comparison with cardiac magnetic resonance","volume":"56","author":"Kim","year":"2015","journal-title":"Yonsei Med J."},{"key":"10.1016\/j.rec.2017.10.028_bib0355","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.echo.2013.02.018","article-title":"Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome","volume":"26","author":"Selamet Tierney","year":"2013","journal-title":"J Am Soc Echocardiogr."},{"key":"10.1016\/j.rec.2017.10.028_bib0360","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJM199904293401702","article-title":"Replacement of the aortic root in patients with Marfan's syndrome","volume":"340","author":"Gott","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2017.10.028_bib0365","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1148\/radiology.219.2.r01ma01535","article-title":"Biophysical properties of the normal-sized aorta in patients with Marfan syndrome: evaluation with MR flow mapping","volume":"219","author":"Groenink","year":"2001","journal-title":"Radiology."},{"key":"10.1016\/j.rec.2017.10.028_bib0370","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/HYPERTENSIONAHA.109.133645","article-title":"Pulse wave velocity assessment by external noninvasive devices and phase-contrast magnetic resonance imaging in the obese","volume":"54","author":"Joly","year":"2009","journal-title":"Hypertension."},{"key":"10.1016\/j.rec.2017.10.028_bib0375","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0895-7061(99)00152-1","article-title":"Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells","volume":"13","author":"Fukuda","year":"2000","journal-title":"Am J Hypertens."},{"key":"10.1016\/j.rec.2017.10.028_bib0380","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","article-title":"Losartan added to beta-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study","volume":"88","author":"Chiu","year":"2013","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.rec.2017.10.028_bib0385","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/eurheartj\/ehs057","article-title":"Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients","volume":"33","author":"Virdis","year":"2012","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2017.10.028_bib0390","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ehj.2003.10.030","article-title":"The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT","volume":"25","author":"Latini","year":"2004","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2017.10.028_bib0395","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0006-291X(03)01451-7","article-title":"Structure-based design of aliskiren, a novel orally effective renin inhibitor","volume":"308","author":"Wood","year":"2003","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.rec.2017.10.028_bib0400","doi-asserted-by":"crossref","first-page":"F929","DOI":"10.1152\/ajprenal.00192.2010","article-title":"A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren","volume":"299","author":"Wu","year":"2010","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1016\/j.rec.2017.10.028_bib0405","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00228-005-0931-8","article-title":"Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension","volume":"61","author":"Anan","year":"2005","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.rec.2017.10.028_bib0410","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","article-title":"Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome","volume":"8","author":"Franken","year":"2015","journal-title":"Circ Cardiovasc Genet."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585717305091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585717305091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T11:23:46Z","timestamp":1535023426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585717305091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1885585717305091"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2017.10.028","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2017.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}